Studies in human HCC cell lines and transgenic mouse models have demonstrated that E2F1 inhibits c-Myc driven apoptosis via PIK3CA/Akt/mTOR and COX-2 pathways and promotes HCC development [77]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.